| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer | Chief Commercial Officer
1 company
Heerma Peter is a Chief Commercial Officer at Travere Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 6 sells.
Estimated insider holdings value: $8.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 8, 2021 | TVTX Travere Therapeutics, Inc. | Chief Commercial Officer | Sell | 2,250 | $31.50 | $70,863.75 | -1.8% | |
| Feb 3, 2021 | TVTX Travere Therapeutics, Inc. | Chief Commercial Officer | Sell | 1,126 | $29.83 | $33,588.58 | -1.0% | |
| Oct 5, 2020 | TVTX Travere Therapeutics, Inc. | Chief Commercial Officer | Sell | 4,376 | $19.13 | $83,691.00 | -4.8% |